CRISPRi-Driven Osteogenesis in Adipose-Derived Stem Cells for Bone Healing and Tissue Engineering
J. D. Weston, B. Austin, H. Levis, J. Zitnay, J. A. Weiss, B. Lawrence, R. D. Bowles
This study uses CRISPRi to downregulate BMP antagonists in adipose-derived stem cells, promoting osteogenesis without exogenous growth factors and demonstrating multiplex tissue engineering applications.
bioRxiv · Nov 15, 2022Bioengineering